Stage IIIA Skin Melanoma Active Not Recruiting Phase 2 Trials for DB00041 (Aldesleukin)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01807182Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaTreatment
NCT01258855Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryTreatment